Cano Health Inc. (CANO)
NYSE: CANO
· Real-Time Price · USD
2.30
-0.05 (-2.13%)
At close: Feb 02, 2024, 10:00 PM
Cano Health Revenue Breakdown
Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|---|
Medicare Revenue | 602.61M | 615.22M | 552.36M | 447.25M | 334.7M |
Medicare Revenue Growth | -2.05% | +11.38% | +23.50% | +33.63% | n/a |
Other Capitated Revenue Revenue | 52.88M | 59.13M | 95.77M | 54.53M | 44.51M |
Other Capitated Revenue Revenue Growth | -10.58% | -38.26% | +75.63% | +22.51% | n/a |
Fee For Service Revenue | 9.7M | 9.97M | 12.82M | 8.18M | 4.39M |
Fee For Service Revenue Growth | -2.70% | -22.22% | +56.78% | +86.28% | n/a |
Other Revenue | 11.42M | 8.5M | 10.47M | 6.75M | 1.35M |
Other Revenue Growth | +34.34% | -18.78% | +55.16% | +400.82% | n/a |
Pharmacy Revenue | 12.76M | 11.52M | 17.99M | 10.1M | 8.22M |
Pharmacy Revenue Growth | +10.80% | -36.00% | +78.22% | +22.87% | n/a |
Operating Expense Breakdown
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 80.82M | 99.42M | 96.47M | 107.83M | 111.77M | 106.18M | 96.59M | 93.35M | 75.93M | 46.57M | 35.29M | 33.73M | 27.39M | 21.86M |
Selling, General, and Administrative Revenue Growth | -18.71% | +3.05% | -10.53% | -3.52% | +5.26% | +9.93% | +3.47% | +22.94% | +63.02% | +31.99% | +4.62% | +23.14% | +25.31% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |